Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Harada

Showing results (1091-1100 of 1,116) with videos related to

Pageof 112
Sort By:
Leukemia|November 22, 2017
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myelomaA Gullà, T Hideshima, G Bianchi, et al.
Toxicologic Pathology|June 23, 2012
Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert WorkshopA P Hall, C R Elcombe, J R Foster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutationsE Iwama, K Sakai, K Azuma, et al.
Leukemia|April 9, 2011
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cellsJ Asano, A Nakano, A Oda, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 11, 2006
Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injuryA Nakao, H Toyokawa, A Tsung, et al.
Nature Biotechnology|March 15, 2022
m<sup>6</sup>A RNA modifications are measured at single-base resolution across the mammalian transcriptomeLulu Hu, Shun Liu, Yong Peng, et al.
Cell Death and Differentiation|July 12, 2008
Yes-associated protein (YAP) functions as a tumor suppressor in breastM Yuan, V Tomlinson, R Lara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)A Inoue, K Kobayashi, M Maemondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2015
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902S Sugawara, S Oizumi, K Minato, et al.
ESMO Open|February 17, 2026
Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancerY Katayama, A Fukuda, R Inoue, et al.
Pageof 112

Showing results (1091-1100 of 1,116) with videos related to

Sort By:
Pageof 112
Leukemia|November 22, 2017
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myelomaA Gullà, T Hideshima, G Bianchi, et al.
Toxicologic Pathology|June 23, 2012
Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert WorkshopA P Hall, C R Elcombe, J R Foster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutationsE Iwama, K Sakai, K Azuma, et al.
Leukemia|April 9, 2011
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cellsJ Asano, A Nakano, A Oda, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 11, 2006
Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injuryA Nakao, H Toyokawa, A Tsung, et al.
Nature Biotechnology|March 15, 2022
m<sup>6</sup>A RNA modifications are measured at single-base resolution across the mammalian transcriptomeLulu Hu, Shun Liu, Yong Peng, et al.
Cell Death and Differentiation|July 12, 2008
Yes-associated protein (YAP) functions as a tumor suppressor in breastM Yuan, V Tomlinson, R Lara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)A Inoue, K Kobayashi, M Maemondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2015
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902S Sugawara, S Oizumi, K Minato, et al.
ESMO Open|February 17, 2026
Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancerY Katayama, A Fukuda, R Inoue, et al.
Pageof 112